Indications And Dose
Reduction of sputum viscosity ▶BY MOUTH ▶Adult: Initially 2.25 g daily in divided doses, then reduced to 1.5 g daily in divided doses, as condition improves
PDF page 328
Drug reference
Reduction of sputum viscosity ▶BY MOUTH ▶Adult: Initially 2.25 g daily in divided doses, then reduced to 1.5 g daily in divided doses, as condition improves
PDF page 328
Active peptic ulceration
PDF page 328
History of peptic ulceration (may disrupt the gastric mucosal barrier)
PDF page 328
Flavours of oral liquid formulations may include cherry, raspberry, cinnamon, or rum.
PDF page 328
Gastrointestinal haemorrhage. skin reactions. Stevens-Johnson syndrome. vomiting
PDF page 328
Manufacturer advises avoid in first trimester.
PDF page 328
No information available.
PDF page 328
There can be variation in the licensing of different medicines containing the same drug. Oral solution ▶Carbocisteine (Non-proprietary) Carbocisteine 50 mg per 1 ml Carbocisteine 250mg/5ml oral solution | 300 ml P £8.55 DT = £6.83 Carbocisteine 75 mg per 1 ml Carbocisteine 750mg/10ml oral solution 10ml sachets sugar-free | 15 sachet P £3.85 DT = £3.85 ▶Mucodyne (Sanofi) Carbocisteine 50 mg per 1 ml Mucodyne Paediatric 250mg/5ml syrup | 125 ml P £12.60 Mucodyne 250mg/5ml syrup | 300 ml P £8.39 DT = £6.83 Capsule ▶Carbocisteine (Non-proprietary) Carbocisteine 375 mg Carbocisteine 375mg capsules | 120 capsule P £18.98 DT = £4.78 ▶Mucodyne (Sanofi) Carbocisteine 375 mg Mucodyne 375mg capsules | 120 capsule P £18.98 DT = £4.78
PDF page 328
Initially 2.25 g daily in divided doses, then
First-line fragment. Read the complete Indications and Dose section above.
PDF page 328